flupirtine has been researched along with Pulmonary Hypertension in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brennan, S; Ghaly, Y; Gurney, AM; Herget, J; Joshi, S; Mizera, R; Novotna, J; Sedivy, V; Zaloudikova, M | 1 |
| Gurney, AM; MacLean, MR; Morecroft, I; Murray, A; Nilsen, M | 1 |
2 other study(ies) available for flupirtine and Pulmonary Hypertension
| Article | Year |
|---|---|
Role of Kv7 channels in responses of the pulmonary circulation to hypoxia.
Topics: Aminopyridines; Analgesics; Animals; Gene Expression Regulation; Hypertension, Pulmonary; Hypoxia; Indoles; KCNQ Potassium Channels; Lung; Male; Membrane Potentials; Muscle, Smooth; Potassium Channel Blockers; Pulmonary Artery; Pulmonary Circulation; Pyridines; Rats; Rats, Wistar; Vascular Resistance | 2015 |
Treatment with the Kv7 potassium channel activator flupirtine is beneficial in two independent mouse models of pulmonary hypertension.
Topics: Aminopyridines; Animals; Disease Models, Animal; Female; Hypertension, Pulmonary; Hypoxia; In Vitro Techniques; Mice; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Potassium Channels, Voltage-Gated; Pulmonary Artery; Serotonin Plasma Membrane Transport Proteins | 2009 |